Fortis Healthcare Limited — Investor Meet, 11-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Fortis Healthcare reported strong Q1 results: consolidated revenue rose 17.5% to INR 2,545 Cr, with hospital revenue up 19% and diagnostics up 10.2%. Consolidated operating EBITDA reached INR 568 Cr (22.3% margin), and PAT grew 4% to INR 263 Cr. Net debt is INR 2,233 Cr (1.01x EBITDA). Key updates include 100 new beds, an O&M hospital in Odisha, and planned proton therapy at Gurgaon. Management reaffirms its 25% EBITDA margin target for FY28, anticipating contributions from ramping-up new facilities and operational efficiencies. Diagnostic business aims for 12-13% revenue growth and 24-25% EBITDA margin. Strategic inorganic growth in core clusters is also being pursued.